Vertex Pharmaceuticals

VRTX Public

NASDAQ exchange • Created Nov 23, 2025

Financial reports

Public filings from SEC EDGAR and company websites.

AI reports

Completed valuation analysis reports.

Last cutoff

Sep 30, 2025

Most recent financial reporting period.

Ticker price

USD 440.05

Updated Apr 13, 2026

Fair value

??? (Subscribe to view)

Updated Nov 23, 2025

AI-generated reports

Track completed analysis reports.

Report name	Report date	Language	Fair value
2025Q3 Analysis	Sep 30, 2025	English	??? (Subscribe to view)

Editorial coverage tied to this company.

Public filings from SEC EDGAR and company websites.